| UNITED STATES |
| SECURITIES AND EXCHANGE COMMISSION |
| Washington, D.C. 20549 |
| Notice of Effectiveness |
| Effectiveness Date: |
February 17,
2026 5:00 P.M.
|
| Form: |
F-4 |
| CIK: |
0002079109 |
| Company Name: |
Veraxa Biotech Holding AG |
| File Number: |
333-289108 |
|
| CIK: |
0002006815 |
| Company Name: |
Voyager Acquisition Corp./Cayman Islands |
| File Number: |
333-289108-02 |
|
| CIK: |
0002079364 |
| Company Name: |
Veraxa Biotech AG |
| File Number: |
333-289108-01 |
|
